-

A score-settling McCarthy to successor: Good luck with these people
The ousted House speaker let loose on fellow Republicans and painted an ugly picture of the state of affairs for whoever succeeds him.
-

McCarthy ouster exposes the Republican Party’s destructive tendencies
By voting to expel Kevin McCarthy as House speaker, Republicans ground the work of Congress to a halt and revealed the danger of governing by chaos.
-

A score-settling McCarthy to successor: Good luck with these people
The ousted House speaker let loose on fellow Republicans and painted an ugly picture of the state of affairs for whoever succeeds him.
-

House Is Paralyzed, With No Speaker After McCarthy Ouster
After a historic vote to remove the speaker, lawmakers departed Washington on Tuesday night with the House of Representatives in chaos and no clear sense of who might lead it.
-

Giuliani’s Drinking, Long a Fraught Subject, Has Trump Prosecutors’ Attention
The former mayor’s drinking has become an investigative subplot in Donald Trump’s federal case over 2020 election interference. But long before that, friends had grown deeply concerned.
-

Generative AI’s Output: How Is It Created, and What IP Rights Should It Receive?
Generative artificial intelligence (AI) first performs broad, deep training on human-created materials, then, when given a prompt, can produce “original” works as output. Examples include ChatGPT (text), Stable Diffusion (images) and Video Diffusion (video)….By: Holland & Knight LLP
-

IRA Drug Price Negotiation Program Litigation Updates – Denial of PI Motion and Motion to Dismiss in Chambers of Commerce Case and New Complaint Filed by Novo Nordisk
Denial of Motion to Dismiss and Motion for Preliminary Injunction in Chambers of Commerce case – On Friday, September 29, the court in Dayton Area Chamber of Commerce et al. v. Becerra et al. (S.D. Ohio, Judge Newman) issued the first substantive order addressing legal challenges to the Drug Price Negotiation Program of the Inflation…
-

Explainer Things: Episode 9
Fall is finally in the air as temperatures drop (in some parts of the country, at least) and football season is in full swing. We’ve previously avoided writing about football because our Explainer Things cast can’t agree on which team to support. Until now, that is. With Taylor Swift’s appearances in Kansas City and New Jersey to root for…
-

Azurity Pharms., Inc. v. Alkem Labs. Ltd. Firvanq® (Vancomycin)
Case Name: Azurity Pharms., Inc. v. Alkem Labs. Ltd., No. 20-cv-1094, 2023 WL 3254117 (D. Del. May 4, 2023) (Goldberg, J.) Drug Product and Patent(s)-in-Suit: Firvanq® (vancomycin); U.S. Patent No. 10,959,948 (“the ’948 patent”)….By: Robins Kaplan LLP
-

OCR Enforcement Action Likely: Reminder of Steps to Take Now
Are you a health care provider, business associate, or other entity subject to the requirements of the Health Insurance Portability and Accountability Act (HIPAA) regarding the use and disclosure of protected health information (PHI)? Do you know whether any of the web pages on your websites or mobile apps use third-party tracking technologies? Do you…